Dr. Reddy's (RDY) is set to acquire Haleon's leading global NRT brand, Nicotinell, and its related portfolio across all formats of the drug for GBP...
Vous n'êtes pas connecté
Dr Reddy's Laboratories is set to acquire Haleon Plc's NRT business, including Nicotinell, for GBP 500 million. The deal encompasses various NRT formats and potential contingent payments. This acquisition marks a significant step for Dr Reddy's in strengthening its position in the global consumer healthcare market outside the US.
Dr. Reddy's (RDY) is set to acquire Haleon's leading global NRT brand, Nicotinell, and its related portfolio across all formats of the drug for GBP...
Updated Date: Thu, 27 Jun 2024 00:00:00 EDT
Updated Date: Thu, 27 Jun 2024 00:00:00 EDT
Updated Date: Wed, 19 Jun 2024 00:00:00 EDT
Updated Date: Wed, 19 Jun 2024 00:00:00 EDT
Updated Date: Tue, 25 Jun 2024 00:00:00 EDT
Updated Date: Thu, 27 Jun 2024 00:00:00 EDT
Updated Date: Thu, 27 Jun 2024 00:00:00 EDT
Updated Date: Mon, 01 Jul 2024 00:00:00 EDT
Updated Date: Mon, 01 Jul 2024 00:00:00 EDT